Follow Dr. Raval:

X icon    LinkedIn icon

Education

  • University of Western Ontario, London, Ontario, Canada – MD
  • University of Western Ontario London Health Sciences Centre, London, Ontario, Canada – Residency in Internal Medicine
  • University of Western Ontario London Health Sciences Centre – Fellowship in Cardiovascular Medicine
  • Georgetown University, Washington D.C. - Interventional Cardiology/Endovascular Medicine Fellowship
  • National Heart Lung and Blood Institute, NIH, Bethesda, Maryland - Intramural Post-Doctoral Fellow, Interventional MRI/Cardiac and Peripheral Interventions/Regenerative Medicine

Professional Activities

Dr. Amish Raval is a faculty member in the Division of Cardiovascular Medicine within the Department of Medicine and holds an affiliate appointment with the Department of Biomedical Engineering in the College of Engineering. He is the recipient of many awards, including NIH R01 and U01 grants and the Wisconsin Alumni Research Foundation Innovation Award for “Best Inventor”.  Dr. Raval is board-certified in internal medicine and cardiovascular diseases. He also holds certification of Added Qualification in Interventional Cardiology. He is a member of numerous professional societies, including the Society for Cardiac Angiography and Intervention, the American College of Cardiology, and the American Heart Association.

Clinical Specialties

Dr. Raval specializes in interventional cardiology, working to minimize the effects of coronary artery disease and valvular heart disease. He performs heart catheterizations to correct valvular and congenital defects and cardiomyopathies, coronary angiography, coronary revascularization, and related coronary and pulmonary procedures. He is the Medical Director of the UW Health STEMI program. 

Research Interests

View Dr. Amish Raval's publications at NCBI My Bibliography

Dr. Amish Raval is a senior, independent translational clinician scientist with over 2 decades of experience in interventional imaging, cardiovascular regenerative medicine, minimally invasive therapeutic delivery of biologic agents, including stem cells and scaffolds for advanced heart and vascular disease. He has >100 scientific peer-reviewed publications and numerous patent inventions. He has led large teams of investigators as a national principal investigator in cardiovascular regenerative medicine clinical trials, including the Stem Cell Revascularization in Patients with Critical Limb Ischemia (SCRIPT-CLI) and the CardiAMP Heart Failure Phase III clinical trials. He is the site investigator of numerous device and biologics trials, and leads the UW Health Options Clinic for patients with advanced cardiovascular disease for whom no further options exist. His busy laboratory is funded through a combination sources including the NIH, Wisconsin Alumni Research Foundation, and Industry Sponsored Research.